Page last updated: 2024-08-24

antineoplaston a10 and Critical Illness

antineoplaston a10 has been researched along with Critical Illness in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bonovas, S; Georgiadou, P; Iacovidou, N; Ioakeimidis, G; Kokoris, S; Konstantinidi, A; Kriebardis, AG; Makrogianni, A; Parastatidou, S; Piovani, D; Sokou, R; Theodoraki, M; Tsantes, AE; Tsantes, AG1

Other Studies

1 other study(ies) available for antineoplaston a10 and Critical Illness

ArticleYear
The Utility of NATEM Assay in Predicting Bleeding Risk in Critically Ill Neonates.
    Seminars in thrombosis and hemostasis, 2023, Volume: 49, Issue:2

    Topics: Blood Coagulation Tests; Cohort Studies; Critical Illness; Hemorrhage; Humans; Infant, Newborn; Thrombelastography

2023